UNIVERSITY OF CINCINNATI

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
1819-01-01
Employees
5.9K
Market Cap
-
Website
https://www.uc.edu/

Nutritional Supplementation in Cognitive Aging

First Posted Date
2008-01-23
Last Posted Date
2016-10-10
Lead Sponsor
University of Cincinnati
Target Recruit Count
120
Registration Number
NCT00599508
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Cincinnati, Cincinnati, Ohio, United States

A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid Leukemia

First Posted Date
2008-01-15
Last Posted Date
2008-10-31
Lead Sponsor
University of Cincinnati
Target Recruit Count
20
Registration Number
NCT00594555
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Cincinnati, Cincinnati, Ohio, United States

Omega-3 Fatty Acid Deficiency Replacement in Early Schizophrenia

First Posted Date
2008-01-03
Last Posted Date
2011-08-02
Lead Sponsor
University of Cincinnati
Registration Number
NCT00585390
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Cincinnati, Cincinnati, Ohio, United States

Modifying Dietary Behavior in Adolescents With Elevated Blood Pressure

First Posted Date
2008-01-03
Last Posted Date
2022-06-14
Lead Sponsor
University of Cincinnati
Target Recruit Count
207
Registration Number
NCT00585832
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

Pilot Study of Betahistine Dihydrochloride in the Treatment of Major Depression With Atypical Features

First Posted Date
2008-01-03
Last Posted Date
2017-07-25
Lead Sponsor
University of Cincinnati
Target Recruit Count
1
Registration Number
NCT00585585
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Cincinnati, Cincinnati, Ohio, United States

Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension

First Posted Date
2007-12-27
Last Posted Date
2013-04-12
Lead Sponsor
University of Cincinnati
Target Recruit Count
43
Registration Number
NCT00581607
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Mount Sinai, New York, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of Cincinnati, Cincinnati, Ohio, United States

๐Ÿ‡บ๐Ÿ‡ธ

Cleveland Clinic, Cleveland, Ohio, United States

and more 1 locations

The Role of Erlotinib an Epidermal Growth Factor Receptor (EGFR) Inhibitor in the Treatment of Myelodysplastic Syndrome

Phase 2
Withdrawn
Conditions
Interventions
First Posted Date
2007-12-10
Last Posted Date
2019-11-25
Lead Sponsor
University of Cincinnati
Registration Number
NCT00570375
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Cincinnati, Cincinnati, Ohio, United States

Nutrient Levels Alter Transplant Outcome

First Posted Date
2007-11-19
Last Posted Date
2007-11-19
Lead Sponsor
University of Cincinnati
Target Recruit Count
54
Registration Number
NCT00560014
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Duke University School Of Medicine, Durham, North Carolina, United States

๐Ÿ‡บ๐Ÿ‡ธ

Washington Hospital, Washington, District of Columbia, United States

Omega-3 Fatty Acid Status in Morbid Obesity Before and After Surgical Treatment

First Posted Date
2007-11-15
Last Posted Date
2016-06-13
Lead Sponsor
University of Cincinnati
Registration Number
NCT00558532
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The Christ Hospital, Cincinnati, Ohio, United States

Use of Armodafinil for Fatigue in Sarcoidosis

Phase 2
Completed
Conditions
Interventions
First Posted Date
2007-11-08
Last Posted Date
2015-05-27
Lead Sponsor
University of Cincinnati
Target Recruit Count
20
Registration Number
NCT00555347
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Cincinnati, Cincinnati, Ohio, United States

ยฉ Copyright 2024. All Rights Reserved by MedPath